Promoting the Quality of Medicines Plus (PQM+)

Diversifying Asia's pharmaceutical supply chain

Pharmaceutical manufacturing across Asia varies significantly by country and product, with countries like Uzbekistan and Kazakhstan relying heavily on essential medicines manufactured by foreign producers. Ensuring the quality of medicines and their source ingredients requires strong coordination between pharmaceutical manufacturers and regulatory agencies, including national quality control laboratories, along with expanded capabilities.

Why it matters

As the primary global producer and exporter of active pharmaceutical ingredients (APIs) and the key starting materials (KSMs) required for API production, China currently dominates the global market for pharmaceutical manufacturing. But relying on a single source or country for medical products and ingredients puts patients at greater risk of supply chain disruptions and drug shortages, ultimately making lifesaving medicines, vaccines, and other medical products difficult to access or unavailable for millions of people.

About the project

To build supply chain resilience, increase regional manufacturing of APIs and KSMs, and promote greater investment in local pharmaceutical industries, USAID is investing in strategies to transform the pharmaceutical market across the region. The Diversifying Asia's Pharmaceutical Supply Chain is a USAID-funded initiative that provides US$5 million in funding to support two central Asian countries, Kazakhstan and Uzbekistan, to strengthen competitive pharmaceutical manufacturing, governance, regulatory systems, procurement, technology, and workforce development to produce quality-assured medical products.


  • Delivered a situational analysis and preliminary findings on the local pharmaceutical industry to regulators in Uzbekistan and Kazakhstan. 
  • Identified 25 APIs that could be produced locally in each country, which will be further prioritized to 10. 
  • Conducted preliminary research on pharmaceutical clusters across countries to gain insights into successful models and best practices to improve technology development in Kazakhstan. 

Related content

Project kick-off in Uzbekistan

USAID launches a $5 million project to spur regional production of active pharmaceutical ingredients in Central Asia 

Read the press release

Expanding manufacturing capacity 

Producing medicines closer to patients builds supply chain resilience and improves health equity. 

Read more